Ranjan Maity

2.1k total citations · 1 hit paper
41 papers, 1.3k citations indexed

About

Ranjan Maity is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ranjan Maity has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 26 papers in Hematology and 17 papers in Oncology. Recurrent topics in Ranjan Maity's work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (15 papers) and CAR-T cell therapy research (13 papers). Ranjan Maity is often cited by papers focused on Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (15 papers) and CAR-T cell therapy research (13 papers). Ranjan Maity collaborates with scholars based in Canada, United States and India. Ranjan Maity's co-authors include Jean‐Yves Masson, Nizar J. Bahlis, Paola Neri, Jai Prakash Sharma, Nihar Ranjan Jana, Noémie Leblay, Claire Wyman, A.S. Arvai, Robert G. Bristow and Elena Petricci and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ranjan Maity

40 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

2023 131 citations Mirco Friedrich, Paola Neri et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ranjan Maity Canada	15	1.0k	498	254	136	130	41	1.3k
Melanie Cornejo United States	11	1.0k 1.0×	381 0.8×	278 1.1×	390 2.9×	74 0.6×	19	1.6k
Jude Canon United States	21	753 0.8×	572 1.1×	134 0.5×	161 1.2×	92 0.7×	45	1.2k
Christopher J. Fry United States	18	1.5k 1.5×	512 1.0×	131 0.5×	106 0.8×	124 1.0×	26	1.8k
Patricia M. Rosten Canada	14	915 0.9×	247 0.5×	310 1.2×	387 2.8×	168 1.3×	17	1.4k
Laurent Malivert France	11	915 0.9×	333 0.7×	112 0.4×	202 1.5×	122 0.9×	11	1.1k
Jennifer A. Perry United States	14	1.5k 1.5×	471 0.9×	182 0.7×	83 0.6×	108 0.8×	16	1.8k
Adam S. Sperling United States	22	1.3k 1.3×	698 1.4×	724 2.9×	253 1.9×	181 1.4×	73	2.1k
Neelam Shirsat India	22	692 0.7×	193 0.4×	113 0.4×	174 1.3×	63 0.5×	53	1.1k
Donatella Venturelli Italy	23	1.1k 1.1×	307 0.6×	638 2.5×	283 2.1×	173 1.3×	58	1.8k
Mala Mani United States	11	1.1k 1.1×	413 0.8×	247 1.0×	132 1.0×	89 0.7×	15	1.4k

Countries citing papers authored by Ranjan Maity

Since Specialization

Citations

This map shows the geographic impact of Ranjan Maity's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjan Maity with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjan Maity more than expected).

Fields of papers citing papers by Ranjan Maity

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranjan Maity. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjan Maity. The network helps show where Ranjan Maity may publish in the future.

Co-authorship network of co-authors of Ranjan Maity

This figure shows the co-authorship network connecting the top 25 collaborators of Ranjan Maity. A scholar is included among the top collaborators of Ranjan Maity based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranjan Maity. Ranjan Maity is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frigault, Melanie M., Beatrix Stelte‐Ludwig, Amy J. Johnson, et al.. (2024). Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma. SHILAP Revista de lepidopterología. 2(1). 100050–100050. 1 indexed citations

Friedrich, Mirco, Paola Neri, Simon Steiger, et al.. (2023). The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. Cancer Cell. 41(4). 711–725.e6. 131 indexed citations breakdown →

Leblay, Noémie, Sungwoo Ahn, Mansour Poorebrahim, et al.. (2023). Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency. Blood. 143(1). 42–56. 14 indexed citations

Poorebrahim, Mansour, Holly Lee, Sacha Benaoudia, et al.. (2023). Bclxl Prevents Progressive Exhaustion in BCMA CAR T Cells with Maintenance of High TCF1 Expressing T Cells. Blood. 142(Supplement 1). 454–454. 2 indexed citations

Gorobets, Evgueni, Koichiro Mihara, Ranjan Maity, et al.. (2022). Identification of ligand linkage vectors for the development of p300/CBP degraders. RSC Medicinal Chemistry. 13(6). 726–730. 5 indexed citations

Lee, Holly, Paola Neri, Sungwoo Ahn, et al.. (2022). Role of TNFRSF17 and GPRC5D Structural and Point Mutations in Resistance to Targeted Immunotherapies in Multiple Myeloma (MM). Blood. 140(Supplement 1). 252–253. 11 indexed citations

Maity, Ranjan, Sacha Benaoudia, Franz J. Zemp, et al.. (2021). A BCL2L1 Armoured BCMA Targeting CAR T Cell to Overcome Exhaustion and Enhance Persistence in Multiple Myeloma. Blood. 138(Supplement 1). 327–327. 8 indexed citations

Leblay, Noémie, et al.. (2020). Deregulation of Adaptive T Cell Immunity in Multiple Myeloma: Insights Into Mechanisms and Therapeutic Opportunities. Frontiers in Oncology. 10. 636–636. 30 indexed citations

Leblay, Noémie, Ranjan Maity, Elie Barakat, et al.. (2020). Cite-Seq Profiling of T Cells in Multiple Myeloma Patients Undergoing BCMA Targeting CAR-T or Bites Immunotherapy. Blood. 136(Supplement 1). 11–12. 44 indexed citations

10.

Neri, Paola, Ranjan Maity, Jean-Baptiste Alberge, et al.. (2019). Mutations and Copy Number Gains of the BCL2 Family Members Mediate Resistance to Venetoclax in Multiple Myeloma (MM) Patients. Blood. 134(Supplement_1). 572–572. 12 indexed citations

11.

Neri, Paola, et al.. (2018). Identification of Specificity Groups in Myeloma Patients T Cell Receptor (TCR) Repertoire through Single Cell TCR Sequencing. Blood. 132(Supplement 1). 4459–4459. 3 indexed citations

12.

Neri, Paola, Ranjan Maity, Peter Duggan, et al.. (2017). Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM). Blood. 130. 123–123. 15 indexed citations

13.

Neri, Paola, Ranjan Maity, Jonathan J. Keats, et al.. (2016). Cereblon Splicing of Exon 10 Mediates IMiDs Resistance in Multiple Myeloma: Clinical Validation in the CoMMpass Trial. Blood. 128(22). 120–120. 7 indexed citations

14.

Buisson, Rémi, Niraj Joshi, Joris Pauty, et al.. (2014). Breast Cancer Proteins PALB2 and BRCA2 Stimulate Polymerase η in Recombination-Associated DNA Synthesis at Blocked Replication Forks. Cell Reports. 6(3). 553–564. 72 indexed citations

15.

Shibata, Atsushi, Davide Moiani, A.S. Arvai, et al.. (2013). DNA Double-Strand Break Repair Pathway Choice Is Directed by Distinct MRE11 Nuclease Activities. Molecular Cell. 53(1). 7–18. 442 indexed citations

16.

Feng, You, Ranjan Maity, Julian P. Whitelegge, et al.. (2013). Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-rich Regions. Journal of Biological Chemistry. 288(52). 37010–37025. 137 indexed citations

17.

Maity, Ranjan, Joris Pauty, Jana Krietsch, et al.. (2013). GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified Proteins. Journal of Visualized Experiments. e50320–e50320. 14 indexed citations

18.

Rao, Sudheendra N.R., Ranjan Maity, Jai Prakash Sharma, et al.. (2010). Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin. Human Molecular Genetics. 19(23). 4726–4734. 55 indexed citations

19.

Maity, Ranjan, Jai Prakash Sharma, & Nihar Ranjan Jana. (2010). Capsaicin induces apoptosis through ubiquitin–proteasome system dysfunction. Journal of Cellular Biochemistry. 109(5). 933–942. 29 indexed citations

20.

Rao, Sudheendra N.R., Jai Prakash Sharma, Ranjan Maity, & Nihar Ranjan Jana. (2009). Co-chaperone CHIP Stabilizes Aggregate-prone Malin, a Ubiquitin Ligase Mutated in Lafora Disease. Journal of Biological Chemistry. 285(2). 1404–1413. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact